OJTS  Vol.3 No.4 , December 2013
CT, MRI, and 18F-FDG PET-CT Findings of Pulmonary Benign Metastasizing Leiomyoma: A Case Report
Here we report imaging studies of a patient with pulmonary benign metastasizing leiomyoma (BML). A 44-year-old woman who underwent a hysterectomy for uterine cellular leiomyoma presented with abnormal shadows on a chest X-ray. Chest computed tomography (CT) revealed multiple well-defined nodules in both lungs. Chest magnetic resonance imaging (MRI) indicated these nodules as T1-low/T2-high intensity lesions. Contrast-enhanced MRI indicated these nodules as well-enhanced lesions, while 18F-fluorodeoxyglucose positron emission tomography-CT revealed no abnormal accumulation in these nodules. Bilateral lung wedge resections were performed for the largest 2 lesions to confirm the diagnosis, and both nodules were histologically diagnosed as BML.

Cite this paper
R. Okita, K. Yasuda, Y. Nojima, A. Maeda, T. Yukawa, S. Saisho, K. Shimizu, T. Akiyama, Y. Miyagi, T. Oda and M. Nakata, "CT, MRI, and 18F-FDG PET-CT Findings of Pulmonary Benign Metastasizing Leiomyoma: A Case Report," Open Journal of Thoracic Surgery, Vol. 3 No. 4, 2013, pp. 127-129. doi: 10.4236/ojts.2013.34026.
[1]   P. E. Steiner, “Metastasizing Fibroleiomyoma of the Uterus: Report of a Case and Review of the Literature,” American Journal of Pathology, Vol. 15, No. 1, 1939, pp. 89-110.

[2]   J. A. Rivera, S. Christopolus, D. Small and M. Trifiro, “Hormonal Manipulation of Benign Metastasizing Leiomyomas: Report of Two Cases and Review of the Literature,” The Journal of Clinical Endocrinology & Metabolism, Vol. 89, No. 7, 2004, pp. 3183-3188. http://dx.doi.org/10.1210/jc.2003-032021

[3]   K. Hoetzenecker, H. J. Ankersmit, C. Aigner, M. Lichtenauer, S. Kreuzer, S. Hacker, W. Hoetzenecker, G. Lang and W. Klepetko, “Consequences of a Wait-and-See Strategy for Benign Metastasizing Leiomyomatosis of the Lung,” The Annals of Thoracic Surgery, Vol. 87, No. 2, 2009, pp. 613-614. http://dx.doi.org/10.1016/j.athoracsur.2008.06.052

[4]   S. Abramson, R. C. Glikeson, J. D. Goldstein, P. K. Woodard, R. Eisenberg and N. Abramson, “Benign Metastasizing Leiomyoma: Clinical, Imaging, and Pathologic Correlation,” AJR, Vol. 176, No. 6, 2001, pp. 1409-1413. http://dx.doi.org/10.2214/ajr.176.6.1761409

[5]   F. Spamaz, M. Ergin, O. Katrancioglu, T. Gonlugur, U. Gonlugur and S. Elagoz, “Benign Metastasizing Leiomyoma,” Lung, Vol. 186, No. 4, 2008, pp. 271-273. http://dx.doi.org/10.1007/s00408-008-9084-8

[6]   V. Scioscio, P. Feraco, L. Miglio, F. Toni, D. Malvi, A. M. Pacilli, L. Fasano, M. Fabbri and M. Zompatori, “Benign Metastasizing Leiomyoma of the Lung: PET Findings,” Journal of Thoracic Imaging, Vol. 24, No. 1, 2009, pp. 41-44. http://dx.doi.org/10.1097/RTI.0b013e31818a0840

[7]   X. Lin, W. Fan, P. Lang, Y. Hu, X. Zhang and X. Sun, “Benign Metastasizing Leiomyoma Identified Using 18FFDG PET/CT,” International Journal of Gynecology & Obstetrics, Vol. 110, No. 2, 2010, pp. 154-156. http://dx.doi.org/10.1016/j.ijgo.2010.03.017

[8]   X. Jin, Y. Meng, Z. Zhu, H. Jing and F. Li, “Elevated 99mTc 3PRGD2 Activity in Benign Metastasizing Leiomyoma,” Clinical Nuclear Medicine, Vol. 38, No. 2, 2013, pp. 117-119. http://dx.doi.org/10.1097/RLU.0b013e318279f14d

[9]   M. Ogawa, M. Hara, Y. Ozawa, S. Moriyama, M. Yano, S. Shimizu and Y. Shibamoto, “Benign Metastasizing Leiomyoma of the Lung with Malignant Transformation Mimicking Mediastinal Tumor,” Clinical Imaging, Vol. 35, No. 5, 2011, pp. 401-404. http://dx.doi.org/10.1016/j.clinimag.2010.11.003

[10]   O. L. Manfredi and J. E. Aruny, “The Role of 99mTc-Bound Phosphates and Grey Scale Echography in the Differentiation of Pelvic Tumors,” Clinical Nuclear Medicine, Vol. 4, No. 3, 1979, pp. 99-107. http://dx.doi.org/10.1097/00003072-197903000-00004